Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: MELANOMA - BLOOD , . Treffer: 22

2016

Hügel, R; Muendlein, A; Volbeding, L; Drexel, H; Richtig, E; Wehkamp, U; Painsi, C; Lange-Asschenfeldt, B; Hauschild, A; Egberts, F Serum levels of hepatocyte growth factor as a potential tumor marker in patients with malignant melanoma.
Melanoma Res. 2016; 26(4):354-360
Web of Science PubMed FullText FullText_MUG

 

2015

Richtig, E; Trapp, EM; Avian, A; Brezinsek, HP; Trapp, M; Egger, JW; Kapfhammer, HP; Rohrer, PM; Berghold, A; Curiel-Lewandrowski, C; Demel, U Psychological Stress and Immunological Modulations in Early-stage Melanoma Patients.
Acta Derm Venereol. 2015; 95(6):691-695 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Zalaudek, I; Kreusch, J; Giacomel, J; Ferrara, G; Catricalà, C; Argenziano, G How to diagnose nonpigmented skin tumors: A review of vascular structures seen with dermoscopy Part I. Melanocytic skin tumors.
J Am Acad Dermatol. 2010; 63(3): 361-374.
Web of Science PubMed FullText FullText_MUG

 

2009

Findeisen, P; Zapatka, M; Peccerella, T; Matzk, H; Neumaier, M; Schadendorf, D; Ugurel, S Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
J Clin Oncol. 2009; 27(13):2199-2208 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Paschen, A; Sucker, A; Hill, B; Moll, I; Zapatka, M; Nguyen, XD; Sim, GC; Gutmann, I; Hassel, J; Becker, JC; Steinle, A; Schadendorf, D; Ugurel, S Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
Clin Cancer Res. 2009; 15(16):5208-5215 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ugurel, S; Utikal, J; Becker, JC Tumor biomarkers in melanoma.
Cancer Control. 2009; 16(3):219-224 [OPEN ACCESS]
Web of Science PubMed FullText

 

2008

Hahn, S; Ugurel, S; Hanschmann, KM; Strobel, H; Tondera, C; Schadendorf, D; Löwer, J; Löwer, R Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability.
AIDS Res Hum Retroviruses. 2008; 24(5):717-723
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Utikal, J; Schadendorf, D; Ugurel, S Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.
Arch Dermatol Res. 2007; 298(10):469-477 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2006

Thoelke, A; Schmid, HP; Figl, R; Schadendorf, D; Ugurel, S Jo-1 positive paraneoplastic systemic sclerosis in a patient with metastatic melanoma.
Eur J Dermatol. 2006; 16(4):428-430 (- Case Report) [OPEN ACCESS]
Web of Science PubMed Google Scholar

 

Wobser, M; Siedel, C; Schrama, D; Brocker, EB; Becker, JC; Vetter-Kauczok, CS Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Arch Dermatol Res. 2006; 297(8):352-357
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Fröhlich, E; Mack, AF; Garbe, C; Klessen, C Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Br J Dermatol. 2005; 153(6):1159-1165
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S Serum markers for melanoma.
Hautarzt. 2005; 56(2):173-184
Web of Science PubMed FullText FullText_MUG

 

2002

Rebmann, V; Ugurel, S; Tilgen, W; Reinhold, U; Grosse-Wilde, H Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients.
Int J Cancer. 2002; 100(5):580-585
Web of Science PubMed FullText FullText_MUG

 

2001

Rappl, G; Hasselmann, DO; Rössler, M; Ugurel, S; Tilgen, W; Reinhold, U Detection of tumor-associated circulating mRNA in patients with disseminated malignant melanoma.
Ann N Y Acad Sci. 2001; 945(5):189-191
Web of Science PubMed

 

Seiter, S; Rappl, G; Tilgen, W; Ugurel, S; Reinhold, U Facts and pitfalls in the detection of tyrosinase mRNA in the blood of melanoma patients by RT-PCR.
Recent Results Cancer Res. 2001; 158(1):105-112
PubMed Google Scholar

 

Ugurel, S; Rappl, G; Tilgen, W; Reinhold, U Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
J Clin Oncol. 2001; 19(2):577-583 [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

Ugurel, S; Rappl, G; Tilgen, W; Reinhold, U Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients.
Clin Cancer Res. 2001; 7(5):1282-1286 [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

2000

Hasselmann, DO; Rappl, G; Rössler, M; Ugurel, S; Tilgen, W; Reinhold, U Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.
Oncol Rep. 2000; 8(1):115-118
Web of Science PubMed

 

1997

Schaider, H; Rech-Weichselbraun, I; Richtig, E; Seidl, H; Soyer, HP; Smolle, J; Kerl, H Circulating adhesion molecules as prognostic factors for cutaneous melanoma.
J Am Acad Dermatol. 1997; 36(2 Pt 1):209-213
Web of Science PubMed Google Scholar

 

1992

BECKER, JC; DUMMER, R; SCHWINN, A; HARTMANN, AA; BURG, G Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy.
J Immunother (1991). 1992; 12(2):147-150
Web of Science PubMed Google Scholar

 

1983

Luger, TA; Linkesch, W; Knobler, R; Kokoschka, EM Serial determination of serum ferritin levels in patients with malignant melanoma.
ONCOLOGY. 1983; 40(4): 263-267.
Web of Science PubMed Google Scholar

 

1979

Linkesch, W; Luger, T; Kokoschka, EM Serum ferritin in patients with malignant melanoma
Acta Med Austriaca Suppl. 1979; 6(42): 346-349.
PubMed

 

© Meduni Graz Impressum